Reinvent Biologics appoints chief medical officer

Fort Worth-based Reinvent Biologics announced the appointment of David Drez Jr., MD, as chief medical officer.

Drez will provide strategic leadership on all of Reinvent Biologics medical education and research activities, the company said in a news release. He will research and track current clinical trends and provide training and support to medical professionals to optimize patient outcomes with Reinvent Biologics products. He will also serve as a resource on Reinvent’s sales efforts.

Drez, with a career spanning more than 42 years, is one of the nation’s leading experts in orthopedics and sports medicine, the company said.

He is co-author of the highly acclaimed Orthopedic Sports Medicine and co-editor of Operative Techniques in Sports Medicine, and was the 2017 recipient of the Jack Weakley Award of Distinction from the National Athletic Trainer’s Association for a lifetime of outstanding contributions directly impacting health care in the area of athletics, athletic training, or sports medicine.

- FWBP Digital Partners -

“Dr. Drez has spent his career sharing his knowledge and experience to future generations of physicians. He is a man of great character with a passion to teach,” Bryant Gaines, CEO of Reinvent Biologics, said in the announcement.

“Throughout his distinguished career, he has elevated the standard of care provided to the patient.

With such a great amount of research coming out on regenerative medicine, Dr. Drez will put us in a position to digest the data and effectively disseminate the knowledge to our distributors and customers,” Gaines said.

Drez earned his undergraduate and medical degrees from Tulane University.

- Advertisement -

“Working with Reinvent Biologics will give me the opportunity to connect orthopedic medicine and regenerative medicine,” Drez said in the news release. “It’s the right time to increase awareness of the true benefits of regenerative medicine.”

Fort Worth-based Reinvent Biologics, LLC discovers, invents, develops, manufactures, and commercializes new and innovative products in the field of regenerative medicine.

reinventbiologics.com

– FWBP Staff